InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
0.00%
)
US TECH 100
17,478.36
(
0.34%
)
Dow Jones
38,675.68
(
0.00%
)
Brent Oil
83.55
(
0.51%
)
Bitcoin
63,657.44
(
-0.53%
)
Post# of 1109
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 253
Posts 17906
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: TheFinalCD post# 527

Thursday, 03/08/2018 2:43:49 PM

Thursday, March 08, 2018 2:43:49 PM

Post# of 1109
In the midst of all the 3-day chart/technicals/squeeze chat, has anyone looked for any fundamental reason ZSAN is headed back to area of $50+? All I saw is a rumored JNJ buy-out, TDA had it too.

Why would JNJ or anyone else be interested in ZSAN? I saw the patent anent migraines, but patent subject matter must ultimately compete well with other migraine drugs to be worthwhile for a TO.

Were there earlier clinical trial results that were not exactly a smashing success, causing Share Price drop some time back? Have further, subsequent events/results proven better than initially thought?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up